Sign in
Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
Journal article   Open access  Peer reviewed

Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes

Peter A Gottlieb, Scott Quinlan, Heidi Krause-Steinrauf, Carla J Greenbaum, Darrell M Wilson, Henry Rodriguez, Desmond A Schatz, Antoinette M Moran, John M Lachin and Jay S Skyler
Diabetes care, Vol.33(4), pp.826-832
2010-04
PMCID: PMC2845036
PMID: 20067954

Abstract

Original Research
url
https://doi.org/10.2337/dc09-1349View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.26 Diabetes
1.26.1016 Type 1 Diabetes
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details